Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
A study experimented VC in combination with each of eribulin mesylate, tamoxifen, fulvestrant, and trastuzumab on a variety of breast cancer cell lines (MCF7, SK-BR3, MDA-MB-231, and breast epithelial cells MCF10A), have shown that high-dose VC with each of those anti-cancer drugs had decreased the cell viability of cancer cells more comprehensively than high-dose of VC or chemotherapy alone (90)
Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Comparing BPC-157 to PRP, Stem Cell Therapy, and Advanced Regenerative Treatments Platelet-Rich Plasma (PRP) Therapy Derived from the patients own blood and concentrated to deliver high levels of growth factors directly to injured areas
Common Side Effects: Hypoglycemia Prevention (Critical) IGF-1's insulin-mimetic effects can lower blood glucose below safe levels
Most commercial topical products contain GHK-Cu at concentrations between 0.05% and 2%
US$ 25.74
US$ 29.56
US$ 22.29
US$ 29.78
US$ 26.71
US$ 28.78
US$ 24.44
US$ 20.90
US$ 20.99
US$ 21.51
